Identifying and adapting treatment for frailty in cardiovascular disease
These meetings are intended for UK Healthcare Professionals and have been developed in accordance with the ABPI Code of Practice.
PM Healthcare events are Quality Assured by the University of Bradford
| Satellite | Identifying and adapting treatment for frailty in cardiovascular disease | |||
| Speakers | Paresh Parmar (Lead Stroke and Care of the Elderly Pharmacist, London North West Healthcare NHS Trust) | |||
| Satellite Description | ||||
|
People are living longer, but not necessarily ageing healthier. Frailty is an important prognostic factor in patients with CVD, and so identifying this feature when assessing these patients may help to individually tailor cardiovascular treatment. Frailty and polypharmacy pose challenges in managing these patients with multiple co-morbidities including cardiovascular disease and their medication. Inappropriate polypharmacy places patients at higher risk of adverse effects and unplanned hospital visits. Understanding what frailty is and how polypharmacy affects frail patients with cardiovascular disease will lead to better medication management through person centred care. . Foundation level. | ||||
